Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1994Current Opinion in Nephrology & Hypertension

Human angiotensin receptor subtypes

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

RSRonald D. SmithUniversity of Central FloridaPPieterDuPont (United States)TTimmermansDuPont (United States)

Discussion

Loading...

Member takes

Overview

AT1 antagonists like losartan merit clinical hypertension trials; extends cell data but leaves human outcomes evidence open.

Structured PICO

I
Intervention
AT1-selective angiotensin II receptor antagonists (e.g., losartan)

This review highlights the pharmacological distinction of angiotensin receptor subtypes and the efficacy of AT1-selective antagonists in blocking angiotensin II effects.

Cite This Study

Smith et al. (1994) studied this question.

synapsesocial.com/papers/6a72dc8ebeb211e5dcf3cf30https://doi.org/10.1097/00041552-199401000-00016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Angiotensin II Receptor Subtypes: Selective Antagonists and Functional Correlates1994 · 94 citations
  2. 2Angiotensin Receptors and Their Therapeutic Implications1996 · 263 citations
  3. 3Recent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System1999 · 473 citations
  4. 4Recent progress in molecular and cell biological studies of angiotensin receptors1995 · 35 citations
  5. 5Angiotensin II Receptor: Molecular Cloning, Functions, and Regulation.1994 · 54 citations